Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity
Amy W Chung, Jenniffer M Mabuka, Bongiwe Ndlovu, Anna Licht, Hannah Robinson, Yathisha Ramlakhan, Musie Ghebremichael, Tarylee Reddy, Philip JR Goulder, Bruce D Walker, Thumbi Ndung'u, Galit Alter
AIDS | LIPPINCOTT WILLIAMS & WILKINS | Published : 2018
Awarded by National Institute of Health
Awarded by Bill and Melinda Gates Foundation CAVD
Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
We thank the study participants, the clinical and laboratory staff of the HIV Pathogenesis Programme. This work was supported by the National Institute of Health (R01 AI080289 and R01 A102660-01), the Bill and Melinda Gates Foundation CAVD (OPP1032817: Leveraging Antibody Effector Function), the Ragon Institute of MGH, MIT and Harvard, the South African Research Chairs Initiative, the Victor Daitz Foundation and an International Early Career Scientist Award from the Howard Hughes Medical Institute to T.N., National Health and Medical Research Council and the American Foundation for AIDS Research Mathilde Krim Fellowship to A.W.C.